A new study examines cancer prevalence across hundreds of vertebrate species. Every multicellular creature, whether soaring ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

Small-cell lung cancer (SCLC) and non-small-cell lung cancer ... They include: The lung cancer stage, which is based on tumor size and whether or not it spread to other areas The type of NSCLC ...

A cancer drug developed ten years ago at UCSF can also put the brakes on one of prostate cancer's deadliest molecular tricks.

An in-depth analysis of ER+ breast cancer, focusing on its prevalence, molecular biology, current treatments, and emerging ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

Cancer researchers at Children's Medical Research Institute have discovered an "unexpected mechanism" that our cells use to ...

Malignant brain tumors have cancer cells. Some grow quickly and others ... where it's located, its size, and your age and health. If you have cancer, it’s important to follow your treatment ...

Humans evolved to our current body size relatively rapidly ... entire limbs—a process that involves lots of cell division, which cancer could exploit. Putting cancer into an evolutionary ...